Evidence map›Paper›PMID 27358802›Full record

ArticlePublic health action2016

Outcomes of antiretroviral therapy among younger versus older adolescents and adults in an urban clinic, Zimbabwe.

C M J Matyanga, K C Takarinda, P Owiti, T Mutasa-Apollo, O Mugurungi, L Buruwe, A J Reid

Open access · diamondAbstract read
In one paragraph

Article in Public health action, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

C M J MatyangaPharmaceutical Technology Department, Harare Institute of Technology, Harare, Zimbabwe.
K C TakarindaAIDS and TB Department, Ministry of Health and Child Care, Harare, Zimbabwe ; International Union Against Tuberculosis and Lung Disease, Paris, France.
P OwitiAcademic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.
T Mutasa-ApolloAIDS and TB Department, Ministry of Health and Child Care, Harare, Zimbabwe.
O MugurungiAIDS and TB Department, Ministry of Health and Child Care, Harare, Zimbabwe.
L BuruwePharmaceutical Technology Department, Harare Institute of Technology, Harare, Zimbabwe.
A J ReidMedical Department, Médecins Sans Frontières, Operational Centre Brussels, MSF-Luxembourg, Luxembourg.
Harare Institute of Technology · ZWMinistry of Health and Child Welfare · ZWAMPATH · KEInternational Union Against Tuberculosis and Lung Disease · FRMédecins Sans Frontières · LU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

settingA non-governmental organisation-supported clinic offering health services including antiretroviral therapy (ART).

objectiveTo compare ART retention between younger (age 10-14 years) vs. older (age 15-19 years) adolescents and younger (age 20-29 years) vs. older (age ⩾30 years) adults and determine adolescent- and adult-specific attrition-associated factors among those initiated on ART between 2010 and 2011.

designRetrospective cohort study.

resultsOf 110 (7%) adolescents and 1484 (93%) adults included in the study, no differences in retention were observed between younger vs. older adolescents at 6, 12 and 24 months. More younger adolescents were initiated with body mass index <16 kg/m(2) compared with older adolescents (64% vs. 47%; P = 0.04). There were more females (74% vs. 52%, P < 0.001) and fewer patients initiating ART with CD4 count ⩽350 cells/mm(3) (77% vs. 81%, P = 0.007) among younger vs. older adults. Younger adults demonstrated more attrition than older adults at all time-points. No attrition risk factors were observed among adolescents. Attrition-associated factors among adults included being younger, having a lower CD4 count and advanced human immunodeficiency virus disease at initiation, and initiation on a stavudine-based regimen.

conclusionYounger adults demonstrated greater attrition and may require more attention. We were unable to demonstrate differences in attrition among younger vs. older adolescents. Loss to follow-up was the main reason for attrition across all age groups. Overall, earlier presentation for ART care appears important for improved ART retention among adults.

Indexed as

attritionHIV/AIDSoperational researchretentionSORT IT

Identifiers

PMID27358802
PMCPMC4913691
OpenAlexW2435673479

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.